OVERVIEW
This interactive, case-based symposium will guide learners through the journey of recognition, screening, and staging of patients at risk of type 1 diabetes (T1D), then discuss management options based on staging results. Expert faculty will share best practices that can be immediately applied to clinical practice, as well as answer questions during the live Q&A at the end.
GOAL STATEMENT
The goal of this activity is to improve screening and staging for T1D, then appropriate management of patients based on T1D stage.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the [list][item]Current trends and gaps in T1D prevalence, development, and treatment in pediatric patients [item]Comparison of guideline-based recommendations for screening and staging patients with suspected T1D or at risk of T1D [item]Clinical trial data for emerging treatments for preventing, delaying, or treating T1D[/list] Have greater competence related to [list][item]Identification of high-risk pediatric patients to be screened for T1D [item]Identification of pediatric patients for whom treatment to delay or prevent T1D would be appropriate[/list]
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]
[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.0 [italic]AMA PRA Category 1 Credits™[/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Supported by an educational grant from [bold]Provention Bio, Inc.[/bold]